Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

Nature Clinical Practice Oncology volume 4, pages 568–569 (2007)Cite this article

boxed-textCuzick J et al. (2007) Long-term results of tamoxifen prophylaxis for breast cancer—96-month follow-up of the randomized IBIS-I trial. J Natl Cancer Inst 99: 272–282

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cuzick J et al. (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360: 817–824

    Article  CAS  Google Scholar 

  2. Rebbeck T et al. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346: 1616–1622

    Article  Google Scholar 

  3. Powles TJ et al. (2007) Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 99: 283–290

    Article  CAS  Google Scholar 

  4. Veronesi U et al. (2007) Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst 99: 727–737

    Article  CAS  Google Scholar 

  5. Fisher B et al. (2005) Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 97: 1652–1662

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. B Bonanni is Co-Director of the Division of Cancer Prevention and Genetics, M Lazzeroni is a Fellow, and U Veronesi is Scientific Director, at the European Institute of Oncology, Milan, Italy.,

    Bernardo Bonanni, Matteo Lazzeroni & Umberto Veronesi

Authors
  1. Bernardo Bonanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matteo Lazzeroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Umberto Veronesi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Umberto Veronesi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bonanni, B., Lazzeroni, M. & Veronesi, U. Does tamoxifen prophylaxis for breast cancer provide long-term prevention?. Nat Rev Clin Oncol 4, 568–569 (2007). https://doi.org/10.1038/ncponc0933

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0933

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing